6-((6-BROMO-2-METHYL-2H-INDAZOL-5-YL)AMINO)-3-((1-METHYL-1H-1,2,4-TRIAZOL-3-YL)METHYL)-1-((2,4,5-TRIFLUOROPHENYL)METHYL)-1,3,5-TRIAZINE-2,4(1H,3H)-DIONE
UNII FNS4Q5UF35
Substance Identification & Data
This profile provides standardized clinical and technical data for 6-((6-bromo-2-methyl-2h-indazol-5-yl)amino)-3-((1-methyl-1h-1,2,4-triazol-3-yl)methyl)-1-((2,4,5-trifluorophenyl)methyl)-1,3,5-triazine-2,4(1h,3h)-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FNS4Q5UF35.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2889341-24-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H17BrF3N9O2 UCKHBROBJXQKJN-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6-((6-bromo-2-methyl-2h-indazol-5-yl)amino)-3-((1-methyl-1h-1,2,4-triazol-3-yl)methyl)-1-((2,4,5-trifluorophenyl)methyl)-1,3,5-triazine-2,4(1h,3h)-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.